InvestorsHub Logo
Followers 91
Posts 3296
Boards Moderated 0
Alias Born 10/18/2010

Re: Tha Part Time Er post# 3508

Tuesday, 04/28/2020 8:05:48 AM

Tuesday, April 28, 2020 8:05:48 AM

Post# of 4873
Japan on board with Gilead's remdesivir, approval expected in May
Apr. 27, 2020 9:18 AM ETGilead Sciences, Inc. (GILD)77 Comments
Gilead Sciences (NASDAQ:GILD) perks up 1% premarket on light volume on the heels of a statement from Japan's Prime Minister Shinzo Abe that health authorities intend to approve antiviral remdesivir next month for the treatment of COVID-19.
Once the company files its application, the Japanese government is set to fast track review and approval. A clinical trial there should wind up in this week.


Uhhhhh ohhhhhh $$$$$$$$ More Positive NEWS here!!!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GILD News